4893 items matching your search terms.

Should home warfarin self management be routine practice? Rationale and progress of the Warfarin SMART study

Dignan, R Keech, A Gebski, V Powell, C Turner, L Bannon, P Bayfield, M Hughes, C

Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer

Duric, VM; Butow, PN; Sharpe, L; Boyle, F; Beith, J; Wilcken, NR; Heritier, S; Coates, AS; Simes, RJ; Stockler, MR

Preferences for adjuvant chemotherapy in early breast cancer: the benefits needed to make extended treatment with docetaxel, doxorubicin, and CMF worthwhile

Duric, V; Francis, P; Simard-Lebrun, J; Chan, A; Chirgwin, J; Harvey, V; Sullivan, A; Simes, RJ; Coates, AS; Stockler, MR

A methodological review of therapeutic impact studies in diagnostic test assessment

Dyer, SM Lei, W Lord, SJ

Expected value of information and decision making in HTA

Eckermann, S Willan, AR

Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2

Edmond, J. J. French, J. K. Aylward, P. E. Wong, C. K. Stewart, R. A. Williams, B. F. De Pasquale, C. G. O'Connell R, L. Van den Berg, K. Van de Werf, F. J. Simes, R. J. White, H. D. Hero- Investigators
EUROPEAN HEART JOURNAL, 2007     DOI:10.1093/eurheartj/ehm087

Taxanes for adjuvant treatment of early breast cancer

Ferguson, T Wilcken, N Vagg, R Ghersi, D Nowak, AK

A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group Study 9601

Findlay, M. Storey, D. Gebski, V. Hargreaves, C. Cullingford, G. Boyer, M. Trotter, J. Archer, S. Davidson, A. Johnston, P. Yuen, J. Dhillon, H. Della-Fiorentina, S. Richardson, G. Truskett, P. Goldstein, D.
ANZ JOURNAL OF SURGERY, 2007     DOI:10.1111/j.1445-2197.2007.04027.x

A pilot study of preoperative and postoperative chemotherapy in patients with operable gastric cancer: Australasian Gastrointestinal Trials Group study 9601

Findlay, M Storey, D Gebski, V Hargreaves, C Cullingford, G Boyer, M Trotter, J Archer, S Davidson, A Johnston, P Yuen, J Dhillon, H Della-Fiorentina, S Richardson, G Truskett, P Goldstein, D on behalf of the AGITG,
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 2007     DOI:10.1111/j.1445-2197.2007.04027.x

TRIPOD: a single arm phase II trial of intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers (ANZGOG 0601)

Gainford, MC Friedlander, M Mueller, H Foo, S Duric, V Stockler, M

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis

Gebski, V. Burmeister, B. Smithers, B.M. Foo, K Zalcberg, J Simes, J Australasian Gastro-Intestinal Trials Group,

Statistical rigour is essential to clinical prediction [letter]

Gebski, V Byth, K Langlands, A

ABC: an AGITG trial of fixed dose rate gemcitabine and cisplatin for patients with advanced biliary tract cancer

Goldstein, D Shannon, J Brown, C Tebbutt, N Ackland, S Van Hazel, G Abdi, E Jefford, M Gainford, MC Adams K, for the Australasian Gastro-Intestinal Trials Group,

Cost analysis of Gamma Knife stereotactic radiosurgery

Griffiths, A Marinovich, L Barton, MB Lord, SJ Griffiths, A Marinovich, L Barton, MB Lord, SJ

Accelerated BEP for germ cell tumours: a current phase I–II trial of the ANZ Germ Cell Trials Group and ANZGOG

Grimison, PS Friedlander, M Toner, GC Thomson, DB Stockler, MR